Treace Medical Concepts, Inc. last reported quarterly results on Aug 7, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $45.4 million (-4.2% year over year) and diluted EPS of -$0.24. It usually reports 9–38 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 5, 2026.
Results for Q3 FY2026, the quarter ending around Sep 30, 2026. Expected on a Thursday. Based on last year's release for the same quarter on Nov 6, 2025. The company has not filed these results with the SEC yet. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 9–38 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 7, 2026
38 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
45
-4.2%
|
-16
+8.8%
|
-0.24
+14.3%
|
|
Apr 9, 2026
9 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
47
-10.2%
|
-18
-12.8%
|
-0.28
-12.0%
|
|
Jan 13, 2026
13 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
63
-9.0%
|
-9
-1775.0%
|
-0.15
-1730.5%
|
|
Nov 6, 2025
37 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
50
+11.4%
|
-16
-6.0%
|
-0.26
-4.0%
|
|
Aug 7, 2025
38 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
47
+6.6%
|
-17
+18.0%
|
-0.28
+17.6%
|
|
May 8, 2025
38 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
53
+2.9%
|
-16
+14.7%
|
-0.25
+16.7%
|
|
Jan 13, 2025
13 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
69
+10.4%
|
-1
+92.0%
|
-0.01
+92.1%
|
|
Nov 5, 2024
36 days after quarter end
|
Q3 FY2024
ended Sep 30, 2024
|
45
+10.6%
|
-15
+12.3%
|
-0.25
+10.7%
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- TMCI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Ponte Vedra, FL
- SEC filer status
- Accelerated filer
- SEC CIK
- 1630627
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.